The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia

Srpski Arhiv za Celokupno Lekarstvo

Volumn 142, Issue 3-4, 2014, Pages 197-203

  Dragović Ivančević, Tijana ^a   Kurtović, Nada Kraguljac ^a   Knežević, Vesna ^a   Bogdanović, Andrija ^a,b   Mihaljević, Biljana ^a,b   Božić, Biljana ^b   Gotić, Mirjana ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Chronic lymphocytic leukemia; Flow cytometry; Immunophenotyping

Indexed keywords

LEUKOCYTE ANTIGEN;

ADULT; AGED; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84932195816     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1404197D     Document Type: Article

References (23)

1. Muller-Hermelink HK, Montserrat E, Catovsky D, Campo E, Harris NL, Stein H. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008. p.180-2.
2. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner R, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008; 111:5446-56.
3. Lin TS, Awan FT, Byrd JC. Chronic lymphocytic leukemia. In: Hoffman R, Benz. Jr EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P, et al., editors. Hematology: Basic Principles and Practice. 5th ed. Churchill Livingstone/Elsevier Philadelphia, USA; 2008. ch.83.
4. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. The French-American-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol. 1989; 42:567-84.
5. Matutes E, Attygalle A, Wotherspoon A, Catovsky D. Diagnostic issues in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol. 2010; 23:3-20.
6. Matutes E, Owusu-Ankomah K, Morilla R, Marco JG, Houlihan A, Que TH, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994; 8:1640-5.
7. Moreau EJ, Matutes E, A'Hern RP, Morilla AM, Morilla RM, Owusu-Ankomah KA, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997; 108:378-82.
8. Chorazzi N, Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood. 2011; 117:1781-91.
9. Bain BJ, Barnett D, Linch D, Matutes E, Reilly JT. Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol. 2002; 24:1-13.
10. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005; 130:325-32.
11. D'Archangelo M. Flow cytometry: new guidelines to support its clinical application Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline, 2nd ed. Cytometry. 2007; 72B:209-10.
12. Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia. 2011; 25:567-74.
13. Delgado J, Matutes E, Morrila AM, Morilla RM, Owusu-Ankomah KA, Rafig-Mohammed F, et al. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. Am J Clin Pathol. 2003; 120:754-9.
14. Pedersen IM, Buhl AM, Klausen P, Gleiser CH, Jurlander J. The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism. Blood. 2002; 99:1314-8.
15. Abbas AK, Lichtman AH, editors. Cellular and Molecular Immunology. 5th ed. Philadelphia: WB Saunders; 2003. p.506-21.
16. Pangalis GA, Angelopolou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C. B-chronic lymphocytic leukemia, small lymphocytic lymphoma and lymphoplasmacytic lymphoma, including Waldemstrom's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders. Semin Hematol. 1999; 36:104-14.
17. Deneys V, Michaux L, Leveugle P, Mazzon AM, Gillis E, Ferrant A, et al. Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by use of CD20 and CD54 expression. Leukemia. 2001; 15:1458-65.
18. DiRaimondo F, Albitar M, Huh Y, Obrein S, Montilo M, Tedeschi A, et al. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative diseases Cancer. 2002; 9:1721-30.
19. Schlette E, Medeiros LJ, Keating M, Lai R. CD79b Expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype. Arch Pathol Lab Med. 2003; 127:561-6.
20. Garcia Vela JA, Delgado I, Benito L, Monteserin MC, Garcia-Alonso L, Somolinos N, et al. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection. Leukemia. 1999; 13:1501-5.
21. Dal-Bo M, Bertoni F, Forconi F, Zucchetto A, Bomben R, Marasca R, et al. Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. J Transl Med. 2009; 7:76-89.
22. Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahe B, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol. 2002; 116:142-50.
23. Leković D, Mihaljević B, Kraguljac-Kurtović N, Peruničić-Jovanović M, Bogdanović A, Čolović M, et al. Prognostic significance of new biological markers in chronic lymphocytic leukaemia. Srp Arh Celok Lek. 2011; 139(11-12):753-8.